In November 2019, which of the following organisations entered into a licensing agreement with AstraZeneca UK Ltd to introduce novel ready-to-use infusion oncology products in China?
1
Cipla Limited
2
Lupin Limited
3
Aurobindo Pharma Limited
4
Sun Pharmaceutical Industries Ltd